1h Free Analyst Time
The addictions therapeutics market is forecasted to grow by USD 10.8 billion during 2023-2028, accelerating at a CAGR of 7.83% during the forecast period. The report on the addictions therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high consumption of alcohol, tobacco, and opioid products, approval of new drugs and launch of digital therapeutics to treat addiction, and initiatives to increase awareness about and combat addiction.
The addictions therapeutics market is segmented as below:
By Distribution Channel
- Hospital pharmacy
- Retail pharmacy
- Others
By Type
- Alcohol addiction therapeutics
- Tobacco addiction therapeutics
- Drug addiction therapeutics
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the addictions therapeutics market covers the following areas:
- Addictions therapeutics market sizing
- Addictions therapeutics market forecast
- Addictions therapeutics market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Distribution Channel
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
360 degree market analysis
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global addictions therapeutics market: Alkermes Public Ltd. Co., Amneal Pharmaceuticals Inc., Aphios Corp., Braeburn Inc., Emergent BioSolutions Inc., GlaxoSmithKline PLC, Glenmark Pharmaceuticals Ltd., Hikma Pharmaceuticals PLC, Indivior PLC, Johnson and Johnson Services Inc., kaleo Inc., Mallinckrodt PLC, Orexo AB, Otsuka Holdings Co. Ltd., Pfizer Inc., Purdue Pharma LP, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Titan Pharmaceuticals Inc., and Viatris Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increasing R&D of novel drugs."
According to the report, one of the major drivers for this market is the high consumption of alcohol, tobacco, and opioid products.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Alkermes Public Ltd. Co.
- Amneal Pharmaceuticals Inc.
- Aphios Corp.
- Braeburn Inc.
- Emergent BioSolutions Inc.
- GlaxoSmithKline Plc
- Glenmark Pharmaceuticals Ltd.
- Hikma Pharmaceuticals Plc
- Indivior Plc
- Johnson and Johnson Services Inc.
- kaleo Inc.
- Mallinckrodt Plc
- Orexo AB
- Otsuka Holdings Co. Ltd.
- Pfizer Inc.
- Purdue Pharma LP
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Titan Pharmaceuticals Inc.
- Viatris Inc.
